Skip to main content
. 2022 Feb 26;27(4):307–313. doi: 10.1093/oncolo/oyac018

Figure 2.

Figure 2.

Distribution of gene mutations on an individual basis. Each row represents an individual. Each column represents one of the 49 genes noted to be differentially mutated stratified by TP53 mutation status. The yellow tick mark designates that the patient contains a mutation in the gene of interest. The background blue color denotes wild-type status. The 49 gene names, in order by column, are as follows: TP53, MDM2, ARID1A, CDK4, PIK3CA, ERBB3, ATM, CDH1, BAP1, TGFBR2, GNAS, CTNNB1, MAP2K1, RNF43, SOX9, MLL2, BCOR, ACVR1B, PTPN11, MED12, CHEK2, NF1, CTCF, MSH3, ARID1A-ARID1A, MAP3K1, CDKN2B, CDH1-CDH1, MLH1, TBX3, MYC, CCNE1, MET, ERBB2, EGFR, CDK6, CCND3, VEGFA, GATA6, EPHB4, FGF19, RAD21, FGF4, FGF3, CCND1, RICTOR, BCL2L1, SRC, FGF10, AKT2, CDKN2A, RB1.